(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 1.34% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.76%.
Quidelortho's revenue in 2025 is $2,741,600,000.On average, 4 Wall Street analysts forecast QDEL's revenue for 2025 to be $184,066,416,545, with the lowest QDEL revenue forecast at $183,365,208,433, and the highest QDEL revenue forecast at $184,840,006,555. On average, 4 Wall Street analysts forecast QDEL's revenue for 2026 to be $190,869,703,736, with the lowest QDEL revenue forecast at $189,854,455,969, and the highest QDEL revenue forecast at $191,886,716,916.
In 2027, QDEL is forecast to generate $198,702,905,195 in revenue, with the lowest revenue forecast at $197,058,016,407 and the highest revenue forecast at $200,347,793,984.